Shares of pharmaceutical firm Merck were heading higher after the company reported second-quarter sales of $10.9 billion this past Friday, beating Wall Street estimates. Adjusted earnings per share of $1.37 was also better than the $1.04 expected. Sales of Merck’s blockbuster cancer drug Keytruda helped offset an 8% decline in revenue to $10.87 billion during … Continue reading “Big Pharma Giant Merck Explodes on Earnings Beat”
Tag: mrk
Biotech & Pharma
Merck Just Received an Upgrade from Goldman Sachs for This Reason
Shares of Merck were on the rise in Monday trading after the pharmaceutical giant received…
April 24, 2018
Biotech & Pharma
Merck Shares Explode After Citi Upgrade
It was a strong day for pharmaceutical company Merck on Wednesday. The stock's shares started…
October 18, 2017
Biotech & Pharma
Merck & Co.(MRK) Just Discontinued This Major Pipeline Drug
Merck & Co. Inc. made a big announcement over its osteoporosis pipeline drug, odanacatib. The…
September 5, 2016
Biogen (BIIB) Shares Explode After WallStreet Report
A report by the Wall Street Journal, indicating that Merck & Co. and Allergan Plc…
August 2, 2016